Join to View Full Profile
311 Albert Sabin WayCincinnati, OH 45229
Phone+1 513-558-5825
Fax+1 513-558-8838
Dr. Reighard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Seth Reighard, MD, is a psychiatrist based in Cincinnati, OH, with a research background in immunology. He completed his medical education and residency at the University of Cincinnati College of Medicine, graduating from medical school in 2021 and completing his residency in 2025. He also holds a PhD in Immunology from the same institution, earned from 2015 to 2019. Dr. Reighard has contributed to several research publications, notably in areas involving immunomodulatory effects, natural killer cell therapies, antiviral immunity, and type 2 immunity in infections, which have been cited multiple times by other researchers. He now studies the overlap between the immune system and psychiatric disease, with a specific focus on the therapeutic potential of microglia in treating mental illness.
Education & Training
University of Cincinnati College of MedicineResidency, 2025- University of Cincinnati College of MedicineClass of 2021
University of Cincinnati College of MedicinePhD, Immunology, 2015 - 2019
Certifications & Licensure
OH State Medical License 2023 - 2027
Publications & Presentations
PubMed
- 1 citationsImmunomodulatory effects of cytokine-induced expansion of cytotoxic lymphocytes in a mouse model of lupus-like disease.Seth D. Reighard, Durga Krishnamurthy, Hilal Cevik, David E. Ochayon, Ayad Ali
Cytotherapy. 2021-01-01 - 18 citationsThe Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection.Sanjeeth Rajaram, Laura M. Canaday, David E. Ochayon, Kelly M. Rangel, Ayad Ali
Immunity. 2020-05-13 - 26 citationsTherapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells.Seth D Reighard, Stacey A Cranert, Kelly M Rangel, Ayad Ali, Ivayla E Gyurova
Cell Reports. Medicine. 2020-04-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
